发明名称 DERIVATIVE OF PYRIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF
摘要 FIELD: organic chemistry, biochemistry, pharmacy. ^ SUBSTANCE: invention relates to derivative of pyridine of the general formula (I): wherein each symbol has the following values: R1 and R2 mean hydrogen, halogen atoms, lower alkyl, lower alkoxy-group; R3 and R4 mean hydrogen atom, lower alkyl, halogen atom; R5 means hydrogen atom, lower alkyl; n = 0 or 1, or its pharmaceutically acceptable salts. Also, invention describes a pharmaceutical composition based on compounds of the formula (I) and intermediates substances used in synthesis. Compounds possess inhibitory effect on activity of phosphodiesterase of type 4. ^ EFFECT: valuable medicinal and biochemical properties of derivatives. ^ 9 cl, 13 tbl, 147 ex
申请公布号 RU2285002(C2) 申请公布日期 2006.10.10
申请号 RU20030136097 申请日期 2002.06.13
申请人 ASTELLAS FARMA INK. 发明人 IVATA MASAKHIRO;KAVANO NORIJUKI;KAIZAVA KHIROJUKI;TAKUVA TOMOFUMI;TSUKAMOTO ISSEI;SEO RIUSI;JAKHIRO KIESI;KOBAJASI MIKI;TAKEUTI MAKOTO
分类号 C07D401/06;A61K31/439;A61K31/4418;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4436;A61K31/4439;A61K31/444;A61K31/4545;A61K31/4709;A61K31/4725;A61K31/496;A61K31/506;A61K31/5355;A61K31/5377;A61K31/55;A61P1/00;A61P1/04;A61P1/16;A61P9/04;A61P9/10;A61P11/00;A61P11/04;A61P11/06;A61P13/12;A61P19/02;A61P29/00;A61P31/04;A61P31/12;A61P37/00;A61P43/00;C07D213/79;C07D213/81;C07D213/89;C07D295/04;C07D401/12;C07D401/14;C07D405/12;C07D409/14;C07D413/12;C07D417/12;C07D487/08 主分类号 C07D401/06
代理机构 代理人
主权项
地址